BPC157 Seven Hills Medical Centr BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Injectable vs. Oral Which is Best Mike Torchia and Kwan James break down the difference between injectable and oral peptides. Injectables are more direct for joints, tissue repair, and BPC 157 in Australia: Benefits, side effects, risks and legality